Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
507
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0911
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.0183 ml/g
Direct iodination
18156463
b3pdb_0912
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.061 ml/g
Direct iodination
18156463
b3pdb_0913
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.054 ml/g
Direct iodination
19818094
b3pdb_0914
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.024 ml/g
Direct iodination
19818094
b3pdb_0915
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.03 ml/g
Direct iodination
18489712
b3pdb_0916
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
NA
NA
NA
NA
% injected dose
0.032 %/g
Direct iodination
29090274
b3pdb_0917
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
20.22%
Direct iodination
18489712
b3pdb_0918
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
79.78%
Direct iodination
18489712
b3pdb_0919
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.0183 ml/g
Direct iodination
18489712
b3pdb_0920
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.0146 ml/g
Direct iodination
18489712
b3pdb_0921
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.0037 ml/g
Direct iodination
18489712
b3pdb_0922
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.002 min-1
Direct iodination
24164260
b3pdb_0923
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
82%
Direct iodination
24164260
b3pdb_0924
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
18%
Direct iodination
24164260
b3pdb_0925
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00044 mL/(g x min)
Direct iodination
24164260
b3pdb_0926
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02584 ml/g
Direct iodination
24164260
b3pdb_0947
CycS
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
-0.1 min-1
Direct iodination
25451468
b3pdb_0948
CycS
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
21.44%
Direct iodination
25451468
b3pdb_0949
CycS
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
78.56%
Direct iodination
25451468
b3pdb_0950
CycS
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00011 mL/(g x min)
Direct iodination
25451468
b3pdb_0951
CycS
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02336 ml/g
Direct iodination
25451468
b3pdb_0952
CycNMe
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
-0.06 min-1
Direct iodination
25451468
b3pdb_0953
CycNMe
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
28.74%
Direct iodination
25451468
b3pdb_0954
CycNMe
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
71.26%
Direct iodination
25451468
b3pdb_0955
CycNMe
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00031 mL/(g x min)
Direct iodination
25451468
b3pdb_0956
CycNMe
Y-cyclo(aGF-(Nω-methylguanidino)A-)-NH2
Tyr-cyclo((D)Ala-Gly-Phe-Nω-methylguanidinoAla-)-NH2
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01812 ml/g
Direct iodination
25451468
b3pdb_0957
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
half life, brain
16.4 min
Direct iodination
12130749
b3pdb_0958
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
Brain elemination rate constant
0.042 min-1
Direct iodination
12130749
b3pdb_0959
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% injected dose
0.01 %/g
Direct iodination
12130749
b3pdb_0960
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% injected dose
0.005 %/g
Direct iodination
12130749
b3pdb_0961
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log P
-1.24
Direct iodination
12130749
b3pdb_0962
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0001852 mL/(g x min)
Direct iodination
30293893
b3pdb_0963
mouse Ghrelin
GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.002847 ml/g
Direct iodination
30293893
b3pdb_0964
ANG1005
(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY
(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.9333 ml/g
H3/C14
18574456
b3pdb_0965
ANG1005
(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY
(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.3111 ml/g
H3/C14
18574456
b3pdb_0966
ANG1005
(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY
(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.5037 ml/g
H3/C14
18574456
b3pdb_0969
Doxorubicin-SynB1
Doxorubicin-linker-RGGRLSYSRRRFSTSTGR
Doxorubicin-linker-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.0684 mL/(g x min)
H3/C14
12164379
b3pdb_0970
Doxorubicin-(D)-Pene
Doxorubicin-linker-rqikiwfqnrrmkwkk
Doxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)Lys
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.77764 ml/g
H3/C14
11123372
b3pdb_0971
Doxorubicin-(D)-Pene
Doxorubicin-linker-rqikiwfqnrrmkwkk
Doxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)Lys
NA
NA
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.072 mL/(g x min)
H3/C14
10727512
b3pdb_0973
Doxorubicin-(D)-SynB
Doxorubicin-linker-rrlsysrrrf
Doxorubicin-linker-(D)Arg-(D)Arg-(D)Leu-(D)Ser-(D)Tyr-(D)Ser-(D)Arg-(D)Arg-(D)Arg-(D)Phe
NA
10
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.9618 ml/g
H3/C14
11123372
b3pdb_0974
SynB3
RRLSYSRRRF-NH2
Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-NH2
NA
10
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.7884 ml/g
H3/C14
11123372
b3pdb_0975
Tat 47-57
YGRKKRRQRRR-NH2
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
NA
NA
NA
11
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.05 min-1
Direct iodination
26465925
b3pdb_0976
Tat 47-57
YGRKKRRQRRR-NH2
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
NA
NA
NA
11
Linear
NA
Chemically synthesized
NA
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
23.05%
Direct iodination
26465925
b3pdb_0977
Tat 47-57
YGRKKRRQRRR-NH2
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
NA
NA
NA
11
Linear
NA
Chemically synthesized
NA
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
76.95%
Direct iodination
26465925
b3pdb_0978
Tat 47-57
YGRKKRRQRRR-NH2
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
NA
NA
NA
11
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00563 mL/(g x min)
Direct iodination
26465925
b3pdb_0979
Tat 47-57
YGRKKRRQRRR-NH2
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
NA
NA
NA
11
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02762 ml/g
Direct iodination
26465925
b3pdb_0980
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.1019 min-1
Direct iodination
26465925
b3pdb_0981
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
19.53%
Direct iodination
26465925
b3pdb_0982
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
80.47%
Direct iodination
26465925
b3pdb_0983
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00602 mL/(g x min)
Direct iodination
26465925
previous
1
2
3
4
5
6
7
8
9
10
11
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD